Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
JASON EHRLICH Insider Profile
4 Followers
JASON EHRLICH, Chief Medical Officer and Chief Development Office at Kodiak Sciences, holds 61.92K shares in Kodiak Sciences (Ticker: KOD).
JASON EHRLICH Kodiak Sciences (KOD)Chief Medical Officer and Chief Development Office
Kodiak Sciences (KOD)
Chief Medical Officer and Chief Development Office
Ranked #3,774 out of 98,564 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+80.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Medical Officer and Chief Development Office
Roles that JASON EHRLICH holds in companies
Most Profitable Insider Trade
The most profitable trade made by JASON EHRLICH
JASON EHRLICH's Trading History
List of latest transactions for each holding click on a transaction to see JASON EHRLICH's performance on stock
You May Also Like
JASON EHRLICH insider profile FAQ
What is the percentage of profitable transactions made by JASON EHRLICH?
The percentage of profitable transactions made by JASON EHRLICH is 80%.
What is the average return per transaction made by JASON EHRLICH?
The average return per transaction made by JASON EHRLICH is 80.70%.
What stocks does JASON EHRLICH hold?
JASON EHRLICH holds: KOD stocks.
What was JASON EHRLICH’s latest transaction?
JASON EHRLICH latest transaction was an Uninformative Sell of $31.50K.
What was JASON EHRLICH's most profitable transaction?
JASON EHRLICH’s most profitable transaction was an Informative Buy of KOD stock on March 24, 2020. The return on the trade was 140.50%.
What is JASON EHRLICH's role in Kodiak Sciences?
JASON EHRLICH's role in Kodiak Sciences is Chief Medical Officer and Chief Development Office.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.